Clinical Trial Update: Laser Interstitial Thermotherapy (LITT) Combined With Checkpoint Inhibitor for Recurrent GBM (RGBM) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating laser interstitial thermotherapy (LITT) combined with a checkpoint inhibitor for recurrent glioblastoma; currently active bu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Checkpoint inhibitor (unspecified)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Glioblastoma, Adult | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING